Unfortunately, LDL-C particle size and insulin resistance were not measured in our study, making it difficult to clarify the underlying mechanism for increased cardiovascular risk of a high AIP in ESRD patients on dialysis. The gene discussed is INS; the disease is autoimmune pancreatitis.